Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul 1;12(3):235-248.

Liquid Biopsy in Thyroid Cancer: New Insight

Affiliations
Review

Liquid Biopsy in Thyroid Cancer: New Insight

Fatemeh Khatami et al. Int J Hematol Oncol Stem Cell Res. .

Abstract

Thyroid cancer, one of the most widespread malignancies of the endocrine-related system that over the past three decades, has a vivid increasing rate. The diagnosis and management of it is dependent on the tumor type and stage. Thyroid cancer is divided into four main types, including PTC (papillary thyroid carcinoma), FTC (follicular thyroid carcinoma), MTC (medullarly thyroid carcinoma), and ATC (anaplastic thyroid carcinoma). The development of the noninvasive diagnostic tool for plasma genotyping, also known as "liquid biopsy", brings a new insight for cancer diagnosis and prognosis. It is mainly containing circulating tumor DNA (ctDNA), circulating tumor cell (CTC), exosomes and extrachromosomal circular DNA (ecDNA). Liquid biopsy as a new plasma genotyping source brings a new prospective of tumor monitoring and therapy. It beneficially reduces the need of tissue biopsy and made early recognition of relapse as well. This article summarizes its components characteristics and their benefit in diagnosis and treatment of thyroid cancer.

Keywords: Biopsy; CTCs; Carcinoma; Endocrine system diseases; Thyroid cancer; cfDNA.

PubMed Disclaimer

Figures

Figure1
Figure1
Main components of liquid biopsy for genetic and epigenetic analysis of thyroid tumors.

Similar articles

Cited by

References

    1. Marrinucci D, Bethel K, Luttgen M, et al. Circulating tumor cells from well-differentiated lung adenocarcinoma retain cytomorphologic features of primary tumor type. Arch Pathol Lab Med. 2009;33(9):1468–71. - PMC - PubMed
    1. Alix-Panabières C, Pantel K. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy. Cancer Discov. 2016;6(5):479–91. - PubMed
    1. Bardelli A, Pantel K. Liquid Biopsies, What We Do Not Know (Yet) Cancer Cell. 2017;31(2):172–179. - PubMed
    1. Jr LAD, Bardelli A. Liquid Biopsies: Genotyping Circulating Tumor DNA. J Clin Oncol. 2014;32(6):579–86. - PMC - PubMed
    1. Mandel P, Metais P. Les acides nucléiques du plasma sanguin chez l'homme. C R Seances Soc Biol Fil. 1948;142(3-4):241–3. - PubMed

LinkOut - more resources